Figure 1.
Figure 1. Overall survival of relapsed/refractory MM patients treated with thalidomide according to ERCC1 (rs735482) genotype (AA=wild-type, CC=homozygous SNP, AC=heterozygous SNP).

Overall survival of relapsed/refractory MM patients treated with thalidomide according to ERCC1 (rs735482) genotype (AA=wild-type, CC=homozygous SNP, AC=heterozygous SNP).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal